Bath & Body Works (NYSE:BBWI – Free Report) had its target price increased by Wells Fargo & Company from $42.00 to $48.00 in a research note published on Wednesday, Benzinga reports. Wells Fargo & Company currently has an equal weight rating on the stock.
Several other equities research analysts also recently weighed in on BBWI. Telsey Advisory Group reaffirmed an outperform rating and issued a $53.00 price objective on shares of Bath & Body Works in a report on Friday, April 5th. Evercore ISI upped their price objective on shares of Bath & Body Works from $30.00 to $45.00 and gave the stock an in-line rating in a report on Friday, March 1st. BMO Capital Markets upped their price objective on shares of Bath & Body Works from $48.00 to $50.00 and gave the stock an outperform rating in a report on Friday, March 1st. Piper Sandler upped their price objective on shares of Bath & Body Works from $44.00 to $45.00 and gave the stock a neutral rating in a report on Tuesday, April 9th. Finally, TD Cowen boosted their price target on shares of Bath & Body Works from $35.00 to $55.00 and gave the stock an outperform rating in a research report on Friday, March 1st. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, Bath & Body Works has an average rating of Hold and a consensus price target of $46.73.
Read Our Latest Report on Bath & Body Works
Bath & Body Works Price Performance
Bath & Body Works (NYSE:BBWI – Get Free Report) last announced its quarterly earnings results on Thursday, February 29th. The company reported $2.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.85 by $0.21. Bath & Body Works had a net margin of 11.82% and a negative return on equity of 37.01%. The company had revenue of $2.91 billion during the quarter, compared to the consensus estimate of $2.84 billion. During the same quarter in the previous year, the company posted $1.86 earnings per share. The company’s revenue for the quarter was up .8% compared to the same quarter last year. As a group, research analysts anticipate that Bath & Body Works will post 3.3 earnings per share for the current fiscal year.
Bath & Body Works Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, March 8th. Shareholders of record on Friday, February 23rd were issued a dividend of $0.20 per share. The ex-dividend date of this dividend was Thursday, February 22nd. This represents a $0.80 annualized dividend and a yield of 1.74%. Bath & Body Works’s payout ratio is presently 20.78%.
Insiders Place Their Bets
In other Bath & Body Works news, insider Thomas E. Mazurek sold 4,285 shares of the business’s stock in a transaction dated Wednesday, March 27th. The stock was sold at an average price of $48.89, for a total transaction of $209,493.65. Following the sale, the insider now owns 45,992 shares in the company, valued at approximately $2,248,548.88. The transaction was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 0.19% of the company’s stock.
Hedge Funds Weigh In On Bath & Body Works
Institutional investors and hedge funds have recently bought and sold shares of the business. Front Row Advisors LLC purchased a new position in Bath & Body Works during the 3rd quarter valued at about $25,000. Trust Co. of Vermont purchased a new position in Bath & Body Works during the 3rd quarter valued at about $27,000. Denali Advisors LLC purchased a new position in Bath & Body Works during the 4th quarter valued at about $27,000. GAMMA Investing LLC purchased a new position in Bath & Body Works during the 4th quarter valued at about $27,000. Finally, Turtle Creek Wealth Advisors LLC purchased a new position in Bath & Body Works during the 4th quarter valued at about $35,000. Hedge funds and other institutional investors own 95.14% of the company’s stock.
About Bath & Body Works
Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.
See Also
- Five stocks we like better than Bath & Body Works
- Insider Selling Explained: Can it Inform Your Investing Choices?
- 3 Stocks Leading the U.S. Agriculture Comeback
- Trading Halts Explained
- How to Use Put Debit Spreads to Profit From Falling Stocks
- What Are Dividends? Buy the Best Dividend Stocks
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.